Bessemer Securities LLC Abb Vie Inc. Transaction History

Bessemer Securities LLC

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 13, 2023	SELL	$133.59 - $154.65 $907,610 - $1.05 Million	-6,794 Reduced 63.05%	3,981 $593,000
Q2 2023 Aug 10, 2023	SELL	$132.51 - $164.9 $139,135 - $173,145	-1,050 Reduced 8.88%	10,775 $1.45 Million
Q1 2023 May 10, 2023	SELL	$144.61 - $166.54 $14,461 - $16,654	-100 Reduced 0.84%	11,825 $1.89 Million
Q4 2022 Feb 13, 2023	BUY	$138.31 - $165.87 $96,817 - $116,109	700 Added 6.24%	11,925 $1.93 Million
Q3 2022 Nov 09, 2022	BUY	$134.21 - $153.93 $107,368 - $123,144	800 Added 7.67%	11,225 $1.51 Million
Q4 2021 Jan 31, 2022	BUY	$107.43 - $135.93 $221,305 - $280,015	2,060 Added 24.63%	10,425 $1.41 Million
Q2 2021 Aug 10, 2021	BUY	$105.21 - $117.21 $68,386 - $76,186	650 Added 8.43%	8,365 $942,000
Q2 2020 Aug 12, 2020	BUY	$73.37 - $98.18 $132,066 - $176,724	1,800 Added 30.43%	7,715 $757,000
Q1 2020 Apr 30, 2020	SELL	$64.5 - $97.79 $8,707 - $13,201	-135 Reduced 2.23%	5,915 $451,000
Q4 2018 May 21, 2019	BUY	$77.85 - $96.01 $470,992 - $580,860	6,050 New	6,050 $558,000

3,853

1.25B

16.8M

12.2M

Ticker ABBV
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,768,099,968
Market Cap $318B
Description
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...

Get notified when there are updates to the investment portfolio of Bessemer Securities LLC, based on Form 13F filings with the SEC.

Stay updated on Bessemer Securities LLC with notifications on news.